Plant Health Care partner with Arysta LifeScience on Harpin research

Plant Health Care (PHC), a leading provider of naturally derived products to the global agriculture markets, announces that it has signed a research agreement with Arysta LifeScience to evaluate Harpin commercially as a foliar spray in combination with a number of Arysta LifeScience’s products.

Harpin is a leading PHC product and has been shown to increase yields significantly on a variety of crops when applied alone or in combination with other active ingredients. Arysta LifeScience will test Harpin formulations in combination with a number of its actives. Harpin technology offers yield improvement as a result of suppression of pests such as nematodes and defense against damaging diseases, as well as additive plant health benefits. Under this agreement, improvements in yield, plant health and product efficacy will be evaluated in a range of crops and environmental situations.

John Brady, CEO of Plant Health Care, commented:”We are excited to establish a testing program with Arysta LifeScience, an innovative global player in the crop protection industry with annual sales of $1.6 billion. Arysta LifeScience has been highly successful in incorporating new technologies into its extensive product portfolio and with its global reach, a successful outcome will be a major benefit to PHC. We are optimistic that Arysta LifeScience’s testing efforts will lead to eventual commercial development of an innovative high return product for growers worldwide.”

Bill Lewis, head of global business initiatives, Arysta LifeScience, said: “Harpin technology has the potential to bring additional value to Arysta LifeScience’s existing line of products and we are excited about the opportunity to evaluate the Harpin technology.”

Plant Health Care just signed Harpin research agreement with MANA Crop Protection a couple days ago (AgroNews 2012-04-26).